Lumexa Imaging Holdings, Inc. (LMRI) stock
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.01−0.62 (-4.24%)
Close on Nov 18, 2026Market cap $1.35BP/E –Yield –
Lumexa Imaging profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 2.6% | +5.5 |
| Q2 FY2026 | Jun 30, 2026 | 1.0% | +4.2 |
| Q1 FY2026 | Mar 31, 2026 | 0.7% | – |
| Q3 FY2025 | Sep 30, 2025 | -1.4% | – |
| Q2 FY2025 | Jun 30, 2025 | -2.9% | – |
| Q1 FY2025 | Mar 31, 2025 | -3.1% | – |
See a number that looks wrong?